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Introduction  
Diabetic retinopathy (DR) is a common cause of blindness in the United Kingdom and all people with diabetes are at 
risk of developing the disease. In 2012, the known UK population with diagnosed diabetes mellitus (DM) was 
reported to be 4 3.8 million people. 1 Future projections from epidemiologic data show that the prevalence of DM in 
the elderly population is an increasing significant public health burden. 2,3  
In terms of chronic diseases, DM is one of the commonest for elderly people 4 and has serious complications such as 
coronary heart disease, nephropathy, neuropathy, and cognitive dysfunction. Subsequently, they often require 
different management to younger people with DM.  
Elderly persons are also very prone to developing visual impairment, 5 with important causes being age-related 
macular degeneration (AMD), glaucoma, and cataract. 5 Proliferative DR is strongly associated with vision loss and 
duration of diabetes is an important factor. 6 – 8 However, previous research suggests that DR is not clearly related 
to advanced age. 9 Although the prevalence of DM is fairly high in elderly persons, the incidence of DR remains 
relatively low. 10,11 Cahill et al 10 reported a 14% prevalence of DR in their cohort of patients diagnosed with DM 
after the age of 70 years. More recently, Xin and Zhaoyan 11 found a DR prevalence of 15.38 – 16.20% and an 
incidence of 8.38/1000 person-years in their study of 2194 elderly subjects aged between 60 and 97 years (mean age 
of 72.5 years). Furthermore, progression from background to proliferative retinopathy has been found in some 
studies to be less common in the elderly, 7 including neovascularisation of the disc. 12  
The NHS Diabetic Eye Screening Programme currently advises that all people with diabetes aged 12 years and over 
should be screened annually for DR. UK screening programmes for other conditions have upper age limits but this 
has not been considered previously for Diabetic Eye Screening. Therefore, the primary aim of this study was to 
evaluate the value of digital DR screening in patients aged 90 years and over in order to establish whether it is 
worthwhile to screen at age 90 years and above.  
Materials and methods  
A search on the Digital Healthcare database of the Birmingham, Solihull and Black Country Screening Programme 
was performed in April 2011. All patients who were 90 years or older at the time of the database search were 
identified. Two-hundred patients were randomly selected from the cohort of patients eligible for screening at the 
age of 90 years or above and a retrospective analysis of this group was performed. The outcomes recorded were 
visual acuity, diabetic retinopathy findings, other ocular findings, and subsequent care in terms of continuing 
screening or referral for ophthalmology clinical assessment.  
For those patients who remained in annual screening and went on to have a second screening episode, data from 
their most recent screening episode was further analysed to generate outcomes including interval between first and 
most recent screen episodes, progression of retinopathy, change in quality of fundus image, and also development 
of new non-DR associated eye conditions detectable on screening. The bene fit of screening patients after 90 years 
of age was then judged based on the occurrence of sight-threatening DR observed at first screening episode aged 90 
years as well as on subsequent screening and/or requirement of referral to hospital ophthalmology clinical care and 
need for laser treatment.  
Results  
At the time point of the database search in April 2011, there were 147 135 patients in the database of whom 5201 
were aged 90 years or over. Conforming to National guideline definitions 46% of these were eligible for screening. 
Two- hundred patients were randomly selected from this latter group for retrospective study and analysis.  
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Of the 200 eligible patients, 142 (71%) were female and 58 (29%) were male. Twenty-one patients were excluded 
from the analysis — 18 did not attend for routine digital screening after attaining the age of 90 years and in 3 an 
attendance for screening was not possible for medical reasons. The remaining 179 (90%) patients had attended 
routine digital screening at least once and the mean number of screens per person was 2 (range 1 – 6). In terms of 
first screening episode aged 90 years, this was also the first recorded screen on the digital healthcare database for 
57% of patients. The age of the first recorded screen for the remaining 43% of patients ranged between 82 and 89 
years, with the mean being 87 years of age. In 45% of patients, the mean duration of DM at time of first screening 
episode aged 90 years was 10 years (range 1 – 63 years). The data were unobtainable or unknown for the remaining 
55% of patients.  
Figure 1 shows the outcomes of first screening episode aged 90 years for all 179 patients. Mean age was 91 years 
(range 90 – 98 years) and the modal Snellen visual acuity (VA) for both eyes was 6/9 (ranges 6/5 — NPL). Of the 179 
patients, 133 (74%) were placed on annual screening, 38 (21%) were referred routinely or urgently for 
ophthalmology clinical assessment, and another 8 (5%) were placed in a digital surveillance clinic. Of the 133 
patients who were placed on annual screening, the final screening outcome was 78 (59%) had no retinopathy and 55 
had either background retinopathy or unassessable image(s). 
 
Figure 1 - Outcome of first screening episode in persons aged 90 years, n=179. Referred routine and referred urgent=referral for 
ophthalmology clinical assessment 
One key finding of this study is that of the 38 patients referred for ophthalmology clinical assessment, the majority ( 
n = 36; 95%) were not referred for DR (see Figure 2), but for other conditions including AMD, retinal vein occlusion, 
glaucoma suspect, unassessable images due to cataract or asteroid hyalosis, or due to technical failure owing to 
insufficient images for grading. Of the five patients referred urgently, four had wet AMD and one had cataract with 
hand movement (HM) VA. A further key finding is that only two patients had diabetic maculopathy and one received 
focal laser treatment (aged 91 years).  
 
Figure  2 Reasons  for  referral  for  ophthalmology  clinical assessment, n=38 
‘ Unassessable images ’ was the most common reason for referral accounting for 23 out of the 38 (61%) patients, 
with cataract accounting for 19 (83%) of these and for 50% of all referrals for ophthalmology clinical assessment. Of 
the 23 patients who had unassessable images, 20 were found to have no referable DR upon subsequent 
ophthalmology clinical assessment. The remaining three patients did not attend their appointment. Of the 19 
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patients who had unassessable images due to cataract, one eye was unassessable in 12 patients and both eyes were 
unassessable in the remaining 7. Five patients subsequently had cataract surgery. The main reasons for patients 
declining surgery were found to be satisfaction with current vision and risk of complications. One patient died 
shortly after referral to ophthalmology and their decision on undergoing cataract surgery was not known.  
Of the 133 patients placed on annual screening, 93 (70%) patients were screened at least once more on annual 
screening. 40 patients had ceased screening. The reasons for this were: 29 were deceased — (average age of death 
was 92 years), five had moved out of the area, three were in care ophthalmology and two were permanently 
inactive. Only one patient remained eligible and did not return in subsequent years. Of the 93 patients who 
underwent repeat screening (range 1 – 6 years), the outcomes were: improved in 8 (9%), stable in 51 (57%), 
deterioration in 31 (34%). Of the latter, 19 patients were referred for ophthalmology clinical assessment; none of 
these for DR. Three patients became unsuitable for digital screening due to mental or physical disability (Figure 3).  
 
Figure 3 -Progression of diabetic retinopathy, change in quality of  fundus  image  and  development  of  new  nondiabetic retinopathy-
associated  eye  conditions  detected  on  repeated digital screening, n = 90. Stable: no change in level of diabetic retinopathy, quality of  
fundus  image,  or  the  presence  of nondiabetic retinopathy-associated eye conditions. Deteriorated: deterioration in level of diabetic 
retinopathy, quality of fundus image, or the presence of new nondiabetic retinopathy-associated eye conditions. Improved: improvement in 
level of diabetic retinopathy, quality of fundus image, or the resolution of nondiabetic retinopathy-associated eye conditions.  
Discussion  
In this study, we found that persons who were older than 90 years of age rarely developed sight-threatening DR 
detected on screening. Regular screening of persons with DM in this age group may therefore not be justified. The 
finding is supported by several previous similar studies. For example, a study published in 1997 which evaluated DR 
in people aged 70 years or older found that ‘ in spite of the high prevalence of diabetes mellitus in the elderly 
population, the prevalence of vision threatening diabetic retinopathy, particularly proliferative retinopathy was low. 
’ 13 Furthermore, Klein et al 7 reported that in their older-onset group, no participant 4 80 years of age developed 
proliferative retinopathy. In another study by Stolk et al , 8 in a total of 6191 patients older than 55 years of age, 
none were found to have proliferative retinopathy. In another small study it was found that retinopathy rates 
increased with age, but only until 70 years. 14  
Our findings showed that annual DR screening is very effective in detecting a wide variety of non-DR related eye 
conditions that are common in the elderly population and the annual screening repeated uptake in the 90 years and 
over age group was high at 70%. In total, approximately a fifth of all patients screened were identified as having 
other eye conditions requiring ophthalmology clinical assessment. In keeping with the published literature, 5,15 the 
majority (95%) of patients were referred for ophthalmology clinical assessment after their first screening episode 
aged 90 years due to non-DR reasons, in particular, media opacity due to cataract which made fundus photography 
difficult or ungradeable. In our study, cataract(s) interfered with successful digital DR screening in 11% of first 
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screening episodes aged 90 years and accounted for 50% of all referrals for ophthalmology clinical assessment. 
However, despite cataract surgery being readily available and effective in restoring vision, 5 only approximately a 
quarter of the patients underwent cataract surgery.  
This study does not answer the exact age that similar findings would be found as we chose an arbitrary age of 90+ 
years. Further studies are required to elucidate whether an age below 90 years could be a suitable cut off. However, 
digital retinal screening does offer opportunistic identification of important non-DR related conditions and therefore 
is an effective way of preventing and restoring visual loss and maintaining the best possible quality of life in this 
population group. 16 Although valuable, this, however, is not the intended purpose of DR screening. The current 
mission statement of the NHS Diabetic Eye Screening Programme is to educe the risk of sight loss among people with 
diabetes by the early detection and treatment, if needed, of sight- threatening DR. We found a low detection rate of 
maculopathy in our screened population of 90 years at 1% and this is a substantially lower rate than 5% of screens 
for maculopathy in systematically screened diabetic populations starting at the age of 12 years.  
Considering the above, our data raise the question as to whether systematic screening should stop at the age of 90 
years. It may be argued that it is more appropriate and cost effective for patients over 90 years of age to be 
encouraged to attend their optometrist on a regular basis rather than with the DR screening programme. This would 
still enable the detection of maculopathy but would also be better suited for the detection of much more prevalent 
non-DR related eye conditions in this group of patients. The optometrist, who could conduct a full ophthalmic 
examination, would also be better placed to refer these elderly patients directly to specific eye clinics, for example, 
cataract, glaucoma, or macular clinics, as and when appropriate.  
In summary, a cut-off age of 90 years was arbitrarily selected in this instance and therefore lower age bands under 
90 years have not been considered as part of this study. Similar analyses could be performed in future studies using 
larger sample sizes to gauge the utility of systematic DR screening in other age brackets. In terms of persons over 90 
years of age, our data and the evidence in the published literature suggest a low utility of the screening programme 
at detecting sight-threatening DR. Altogether with the high prevalence of non-DR related eye conditions, we feel 
that the intended purpose of the NHS Diabetic Eye Screening Programme is not ful filled in this age group of patients 
and screening may be better performed in optometric practice.   
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